Topics: M&A

Private Equity Giant to Buy WebMD

Private Equity Giant to Buy WebMD

One of the world’s biggest and the most known private equity firms is buying an online health publisher WebMD Health Corp. The parties announced the deal on Monday evening, stating the deal would be worth around $2.8 billion.   The financials of the deal   Private equity giant KKR will pay $66.50 per share, which is a premium of 20.5% [...]

PE Firms Compete to Buy CARE Hospitals in India

PE Firms Compete to Buy CARE Hospitals in India

  Private equity firm Advent International announced it is looking to sell its stake in the Indian hospital chain CARE Hospitals, but it looks another private equity firm could take its place. Big firms are set to battle it out for the healthcare business, with negotiations aiming to find a buyer by the end of the month.   The Possible [...]

Private Equity Firm Cinven to Buy Synlab

Private Equity Firm Cinven to Buy Synlab

  Private equity deals in the healthcare sector keep rolling in, as reports on Thursday suggested private equity firm Cinven is buying the German medical laboratory operator Synlab. The firm is merging the German-based company with its recently acquired French company, Labco.   The Details of the Deal   The European private equity firm is buying the laboratory operator for [...]

CVC and Temasek Strike a Deal to Buy a Generic Drugs Firm

CVC and Temasek Strike a Deal to Buy a Generic Drugs...

  The healthcare sector has witnessed some big deals this year, with pharmaceutical companies receiving special attention from private equity firms. Another big deal was announced on Monday, when European private equity fund CVC and Singaporean sovereign wealth fund Temasek announced the purchase of a controlling stake in Alvogen.   The Transaction Details   Robert Wessman, the former chief executive [...]

Finding PE Gems in the Overheated Healthcare Sector

Finding PE Gems in the Overheated Healthcare Sector

Bain has published a global healthcare report uncovering some of the areas where private equity investors might find deals. As reported earlier this month, PE is being squeezed out of the hot healthcare sector as M&A activity by strategic investors climbs to unprecedented levels. Bain unearthed a group of global top performers, which it described as large but narrowly focused [...]

TPG Capital To Sell Drugmaker Par in an $8.05bn Deal

TPG Capital To Sell Drugmaker Par in an $8.05bn Deal

Private equity firm TPG Capital is set to sell the generic drugmaker company Par to Endo. The Dublin-based pharmacy group’s acquisition of Par will create a top-five global drugmaker in the world in terms of US sales. The deal will be worth $8.05 billion.   The US-based drugmaker currently has a portfolio of around 100 products, which includes oral solids [...]

Private Equity Firm Stone Point Capital Acquires Situs Holdings

Private Equity Firm Stone Point Capital Acquires ...

One of the biggest acquisitions of early 2015 happened on Tuesday afternoon when the deal between Stone Point Capital and Situs Holdings was announced. It is believed the commercial real-estate service firm will be sold to the private equity firm in a deal worth nearly $200 million.   Speculation over the Deal The first speculation broke in the early hours [...]

M&A Fever Hits Pharma Industry

M&A Fever Hits Pharma Industry

In the last week there has been an eye popping 168 billion dollars in M&A deals rumored and/or announced by some of the world’s largest pharmaceutical companies, as well as wannabe giants. Rumors that Pfizer will bid around USD 100 billion for rival AstraZeneca were reported on the weekend. On Monday, Canadian drugmaker Valeant Pharmaceuticals International said it had teamed [...]

Pharmaceutical Firm Alvogen Sells for $700million

Pharmaceutical Firm Alvogen Sells for $700million

Pamplona Capital Management, an investment manager with offices in London, New York City, and on the island of Malta, has acquired a majority stake in pharmaceutical company Alvogen, who themselves are headquartered in Luxembourg.   The news has been announced on the Alvogen website as well as by various news sources, including Businessweek and Digital Journal, while a Press Release [...]

Biotech and Pharma: Improved Returns in 2011

Biotech and Pharma: Improved Returns in 2011

HBM Partners, an active investor in the life sciences sector, says that 2011 was a “very strong” year for companies in biopharma, with a high level of M&A activity, large and small. Its latest report says that the average return multiples to investors (based on upfront payments) for VC-backed company sales jumped to 2.8x (up from 1.6x in 2010). If [...]